CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes:: Involvement of NF-κB, AP-1, and C/EBP

被引:135
作者
Baccam, M
Woo, SY
Vinson, C
Bishop, GA
机构
[1] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[3] Vet Affairs Med Ctr, Iowa City, IA 52242 USA
[4] NCI, Biochem Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.170.6.3099
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Engagement of CD40 by its ligand CD154 induces IL-6 production by B lymphocytes. We previously reported that this IL-6 production is dependent upon binding of the adapter protein TNF receptor-associated factor 6 to the cytoplasmic domain of CD40, while binding of TNF receptor-associated factors 2 and 3 is dispensable, as is the activation-induced nuclear translocation of NF-kappaB. The present study was designed to characterize CD40-mediated transcriptional control of the IL-6 gene in B cells. CD40 engagement on B lymphocytes activated the IL-6 promoter, and mutations in the putative binding sites for AP-1 and C/EBP transcription factors reduced this activation. Interestingly, a mutation in the putative NF-kappaB binding site completely abrogated the basal promoter activity, thus also rendering the promoter unresponsive to CD40 stimulation, suggesting that this site is required for binding of NF-kappaB constitutively present in the nucleus of mature B cells. The expression of dominant negative Fos or C/EBPalpha proteins, which prevent binding of AP-1 or C/EBP complexes to DNA, also reduced CD40-mediated IL-6 gene expression. Furthermore, CD40 stimulation led to phosphorylation of c-Jun on its activation domain, implicating CD40-mediated Jun kinase activation in the transcriptional regulation of IL-6 production.
引用
收藏
页码:3099 / 3108
页数:10
相关论文
共 54 条
[11]  
BISHOP GA, 1991, J IMMUNOL, V147, P1107
[12]   The immune response modifier resiquimod mimics CD40-induced B cell activation [J].
Bishop, GA ;
Ramirez, LM ;
Baccam, M ;
Busch, LK ;
Pederson, LK ;
Tomai, MA .
CELLULAR IMMUNOLOGY, 2001, 208 (01) :9-17
[13]   ACTIVATION OF PROTEIN-KINASE-C DECREASES PHOSPHORYLATION OF C-JUN AT SITES THAT NEGATIVELY REGULATE ITS DNA-BINDING ACTIVITY [J].
BOYLE, WJ ;
SMEAL, T ;
DEFIZE, LHK ;
ANGEL, P ;
WOODGETT, JR ;
KARIN, M ;
HUNTER, T .
CELL, 1991, 64 (03) :573-584
[14]  
Busch LK, 1999, J IMMUNOL, V162, P2555
[15]   INDUCTION OF C-FOS EXPRESSION THROUGH JNK-MEDIATED TCF/ELK-1 PHOSPHORYLATION [J].
CAVIGELLI, M ;
DOLFI, F ;
CLARET, FX ;
KARIN, M .
EMBO JOURNAL, 1995, 14 (23) :5957-5964
[16]  
CHAUHAN D, 1994, BLOOD, V84, P2243
[17]  
CLARK EA, 1990, J IMMUNOL, V145, P1400
[18]   IG/EBP (C/EBP-GAMMA) IS A TRANSDOMINANT NEGATIVE INHIBITOR OF C/EBP FAMILY TRANSCRIPTIONAL ACTIVATORS [J].
COOPER, C ;
HENDERSON, A ;
ARTANDI, S ;
AVITAHL, N ;
CALAME, K .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4371-4377
[19]  
COOPER CL, 1994, J IMMUNOL, V153, P5049
[20]   What is the real role of CD40 in cancer immunotherapy? [J].
Costello, RT ;
Gastaut, JA ;
Olive, D .
IMMUNOLOGY TODAY, 1999, 20 (11) :488-493